Study to determine the appropriate age for a second immunization with the Meningococcal C conjugated vaccine.
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 27 Jun 2016
At a glance
- Drugs Meningococcal vaccine group C conjugate (Primary)
- Indications Meningococcal group C infections
- Focus Pharmacodynamics
- Acronyms TIM
- 29 Jul 2012 Planned number of patients changed from 246 to 268 as reported by Netherlands Trial Register.
- 29 Jul 2012 Status changed from recruiting to active, no longer recruiting as reported by Netherlands Trial Register.
- 29 Jul 2012 New source identified and integrated (Netherlands Trial Register; NTR3521).